Magnetic resonance imaging of the breast

Cancer Control

Volumn 8, Issue 5, 2001, Pages 399-406

  Goscin, Christopher P ^a   Berman, Claudia G ^b   Clark, Robert A ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST AUGMENTATION; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOMAMMOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; TREATMENT PLANNING;

EID: 0034804945     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480100800502     Document Type: Article

References (79)

1. MRI of the breast
2. MR imaging of the breast
3. MR imaging of the breast
4. Breast magnetic resonance imaging
5. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent
6. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
7. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy
8. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach
9. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
10. Breast carcinoma: MR imaging before re-excisional biopsy
11. Radiotherapy to the conserved breast: Is it avoidable if the cancer is small?
12. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five year results of a randomized trial
13. Silicone breast implants in vivo: MR imaging
14. Breast augmentation: A risk factor for breast cancer?
15. Breast cancer in women after augmentation mammoplasty
16. Breast cancer diagnosis in women augmented with silicone gel-filled implants
17. Breast cancer diagnosis in women with subglandular silicone gel-filled augmentation implants
18. The effect of breast implants on the radiographic detection of microcalcification and soft-tissue masses
19. Breast cancer: Mammographic and sonographic findings after augmentation mammoplasty
20. Mammography and breast implants
21. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery
22. Comparative silicone breast implant evaluation using mammography, sonography, and magnetic resonance imaging: Experience with 59 implants
23. Diagnosing breast implant rupture with MR imaging, US, and mammography
24. MR imaging of breast implants
25. Linguine sign at MR imaging: Does it represent the collapsed silicone implant shell?
26. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
27. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma
28. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer
29. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast
30. MR imaging of the breast in patients with occult primary breast carcinoma
31. MRI of the breast in patients with metastatic disease of unknown primary
32. Staging of breast cancer with MR imaging
33. Magnetic resonance imaging detection and wire localization of an "occult" breast cancer
34. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy
35. MR depiction of occult breast cancer in patients with malignant axillary adenopathy
36. MRI of breast cancer: Influence of chemotherapy on sensitivity
37. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy
38. Evaluation of therapeutic response with dynamic high-resolution MR imaging in patients with early breast cancer
39. Cancer statistics, 2000
40. Genetic predisposition to breast cancer
41. High risk screening working group report
42. Population genetics of BRCA1 and BRCA2
43. Risks of cancer in BRCA1-mutation carriers
44. Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes?
45. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
46. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
47. NCCN practice guidelines: Genetics/familial high-risk cancer screening
48. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2
49. Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
50. Age-specific sensitivities of mammographic screening for breast cancer
51. Efficacy of screening mammography: A meta-analysis
52. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials
53. Effect of mammographic breast density on breast cancer screening performance: A study in Nijmegen, the Netherlands
54. Breast cancer visualized by mammography in patients under 35
55. Breast-cancer screening with mammography in women aged 40-49 years
56. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
57. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2
58. "At risk" for breast cancer
59. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations
60. Mammography and hereditary breast cancer
61. Breast cancer induction due to mammography screening in hereditarily affected women
62. Hereditary breast cancer and possible risk of mammography
63. Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
64. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results
65. Earlier detection of breast cancer by surveillance of women at familial risk
66. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer
67. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer
68. MR imaging of ductal carcinoma in situ
69. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
70. International investigation of breast MRI: Results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions
71. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: Are time-signal intensity curves an accurate predictor?
72. MR Imaging of the breast: Fast imaging sequences with and without Gd-DTPA-preliminary observations
73. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
74. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency
75. Menstrual cycle and age: Influence on parenchymal contrast medium enhancement in MR imaging of the breast
76. Prototype breast coil for MR-guided needle localization
77. MR-guided biopsy of suspect breast lesions with a simple stereotaxic add-on-device for surface coils
78. MR mammographic localization. Work in progress